Skip to main content
. 2024 Oct 16;67(20):18124–18138. doi: 10.1021/acs.jmedchem.4c01251

Table 4. Study Arms in the NCI-N87 Second Run.

group N agent mg/kg
1 10 vehicle  
2 10 trastuzumab-deruxtecan (enhertu) 2.5
3 10 trastuzumab-deruxtecan (enhertu) 1.25
4 10 ADC 7 (AJICAP, APL-1092) 10
5 10 ADC 7 (AJICAP, APL-1092) 5.0
6 10 ADC 7 (AJICAP, APL-1092) 2.5
7 10 ADC 9 (interchain-break, APL-1092) 2.5
8 10 ADC 9 (interchain-break, APL-1092) 1.25